ConductScience.org, home

Paper36764320

Global reporting of progress towards elimination of hepatitis B and hepatitis C.

Cui F and 20 others. Lancet Gastroenterol Hepatol, 2023. Cited by 271 papers, by iCite.

Cite this record

ConductScience Library. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Papers, record 36764320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36764320

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Global reporting of progress towards elimination of hepatitis B and hepatitis C.
PubMed
Journal
Lancet Gastroenterol Hepatol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
271
iCite
Relative citation ratio, by iCite
32.4
iCite
Revised in PubMed
2025-05-30
PubMed

Authors21

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cui FFuqiang
2Blach SSarah
3Manzengo Mingiedi CCasimir
4Gonzalez MAMonica Alonso
5Sabry Alaama AAhmed
6Mozalevskis AAntons
7Séguy NNicole
8Rewari BBBharat Bhushan
9Chan PLPo-Lin
10Le LVLinh-Vi
11Doherty MMeg
12Luhmann NNiklas
13Easterbrook PPhilippa
14Dirac MMae
15de Martel CCatherine
16Nayagam SShevanthi
17Hallett TBTimothy B
18Vickerman PPeter
19Razavi HHomie
20Lesi OOlufunmiayo

Source PubMed

See all 21 authorsDownload CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis B, ChronicMajor topic
Hepatitis C, ChronicMajor topic
Hepatitis CMajor topic
Hepatitis BMajor topic
Hepatitis, Viral, HumanMajor topic
Hepatitis AMajor topic
Humans
Antiviral Agents
Hepacivirus

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
001World Health OrganizationInternationalPubMed
MR/R015600/1Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in36764321Strategic information to guide elimination of viral hepatitis.https://conductscience.org/library/papers/36764321

Source PubMed

Download CSV of comments and corrections

Cited by191

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 271 citations.

PMIDTitleJournalYearIn PapersSource
42983274Influence mechanism of social norms on prescribing behavior for chronic hepatitis B and its variation between different prescriber subgroups.BMC Prim Care2026https://conductscience.org/library/papers/42983274PubMed
42977965
Association between awareness of government notification and 'negative hepatitis virus test result card' and implementation of hepatitis B and C screening in Japanese workplaces: a cross-sectional study.
BMC Public Health2026https://conductscience.org/library/papers/42977965PubMed
42959244The hidden burden of viral hepatitis B and C in healthcare settings: a cross-sectional study of seroprevalence, predictors, and occult infection.Front Public Health2026https://conductscience.org/library/papers/42959244PubMed
42934603Communicating hepatitis B: a content, readability and suitability assessment of Australian hepatitis B patient resources.BMC Public Health2026https://conductscience.org/library/papers/42934603PubMed
42882394Clinical Performance of the Elecsys HCV Duo Immunoassay Compared with a Standard-of-Care Algorithm Using Alinity Anti-HCV Screening and HCV RNA Confirmation.Diagnostics (Basel)2026https://conductscience.org/library/papers/42882394PubMed
42797761Emergency Department-Based Screening and Linkage-to-Care for Hepatitis B, C, and D in a Referral Hospital in Barcelona, Spain: Reduction in Hepatitis C Prevalence After Five Years.Viruses2026https://conductscience.org/library/papers/42797761PubMed
42741255Trends and forecasting of reported hepatitis B and hepatitis C incidence in Hainan Province, China, 2005-2020.Front Epidemiol2026https://conductscience.org/library/papers/42741255PubMed
42703992Machine Learning Model for Predicting Hepatocellular Carcinoma Development in Patients With Hepatitis B Virus-Related Cirrhosis Receiving Antiviral Therapy.Kaohsiung J Med Sci2026https://conductscience.org/library/papers/42703992PubMed
42668088Hepatitis B Surface Antigen Directly Alters Dendritic Cell-Mediated Natural Killer Cell Responses.Cell Mol Gastroenterol Hepatol2026https://conductscience.org/library/papers/42668088PubMed
42655715Unraveling HBV Life Cycle by Fluorescent Microscopy Imaging.Viruses2026https://conductscience.org/library/papers/42655715PubMed
42554489Rapid, low-cost, and portable molecular detection of HIV-1 subtype B and HCV 1a directly from blood.Microbiol Spectr2026https://conductscience.org/library/papers/42554489PubMed
42483732Chronic Hepatitis B in the Asia-Pacific Region: Results of the 2023 Global Burden of Disease Study.J Clin Transl Hepatol2026https://conductscience.org/library/papers/42483732PubMed
42458322Spatiotemporal epidemiology of hepatitis B in Central China: urbanization drivers and implications for adult-targeted control strategies.BMC Public Health2026https://conductscience.org/library/papers/42458322PubMed
42414971Development and validation of a machine learning model for evidence of prior or current HCV infection: a demographic screening approach for the US population.BMC Public Health2026https://conductscience.org/library/papers/42414971PubMed
42393060Projected health benefits and cost offsets from the United States National Hepatitis C Elimination Initiative.Nat Commun2026https://conductscience.org/library/papers/42393060PubMed
42381729Noninvasive Prediction of Significant Hepatic Injury in Treatment-Naïve Children with Chronic HBV Infection.Infect Drug Resist2026https://conductscience.org/library/papers/42381729PubMed
42352282Natural Alkaloids Against Liver Injury: Mechanistic Insights and Multi-Target Therapeutic Potential.Biomolecules2026https://conductscience.org/library/papers/42352282PubMed
42328238Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children.Infect Dis Immun2024https://conductscience.org/library/papers/42328238PubMed
42325858Epidemiology, natural history, and outcome of chronic hepatitis B in children.Infect Dis Immun2025https://conductscience.org/library/papers/42325858PubMed
42292767Modeling Highlights the Challenge of Achieving and Maintaining Hepatitis C Virus Micro-Elimination Among People Who Inject Drugs.Open Forum Infect Dis2026https://conductscience.org/library/papers/42292767PubMed

See all 191 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36764320

GET https://conductscience.org/api/papers/v1/36764320/authors?page=2